rs61742871
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BS1_SupportingBS2
The NM_002334.4(LRP4):āc.3064A>Gā(p.Asn1022Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,614,078 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP4 | NM_002334.4 | c.3064A>G | p.Asn1022Asp | missense_variant | 22/38 | ENST00000378623.6 | NP_002325.2 | |
LRP4 | XM_017017734.2 | c.3064A>G | p.Asn1022Asp | missense_variant | 22/39 | XP_016873223.1 | ||
LRP4 | XM_011520103.3 | c.2260A>G | p.Asn754Asp | missense_variant | 16/32 | XP_011518405.1 | ||
LRP4 | XM_011520104.3 | c.829A>G | p.Asn277Asp | missense_variant | 7/23 | XP_011518406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP4 | ENST00000378623.6 | c.3064A>G | p.Asn1022Asp | missense_variant | 22/38 | 1 | NM_002334.4 | ENSP00000367888.1 |
Frequencies
GnomAD3 genomes AF: 0.000940 AC: 143AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00102 AC: 257AN: 251466Hom.: 0 AF XY: 0.00102 AC XY: 139AN XY: 135902
GnomAD4 exome AF: 0.00110 AC: 1610AN: 1461888Hom.: 2 Cov.: 32 AF XY: 0.00104 AC XY: 754AN XY: 727244
GnomAD4 genome AF: 0.000940 AC: 143AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000767 AC XY: 57AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 11, 2021 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 13, 2017 | - - |
Cenani-Lenz syndactyly syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
LRP4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at